Statistics
Publications
8
Citations
1.4K
H-Index
8
Active since
2015
Affiliations
Novo Nordisk (Denmark)(Current)
Thomas Kruse is an author at Novo Nordisk (Denmark) specializing in pharmacology, endocrinology, and metabolic regulation.
Publications per year
2015–2025
8
8
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Jesper Lau, Paw Bloch, Lauge Schäffer et al. · Journal of Medicinal Chemistry · 2015 · 1K citations · Full text
Development of Cagrilintide, a Long-Acting Amylin Analogue
Thomas Kruse, Jakob Lerche Hansen, Kirsten Dahl et al. · Journal of Medicinal Chemistry · 2021 · 120 citations
Madeleine M. Fletcher, Peter Keov, Tin T. Truong et al. · Journal of Pharmacology and Experimental Therapeutics · 2021 · 66 citations · Full text
Glucose-sensitive insulin with attenuation of hypoglycaemia
Thomas Høeg-Jensen, Thomas Kruse, Christian L. Brand et al. · Nature · 2024 · 56 citations · Full text
Medicine, Endocrinology, Diabetology +15
1–5 of 8